Every additional step up to around 10,000 steps per day reduces the risk of death and cardiovascular disease (CVD), regardless of how much remaining time is spent sedentary, reports a large population-based study published online in the British Journal of Sports Medicine.
Blenrep-Based Regimen Yields PFS Benefit in Relapsed/Refractory Myeloma
CHICAGO — Progression-free survival (PFS) was significantly higher with belantamab mafodotin (belamaf; Blenrep) combined with pomalidomide (Pomalyst) and dexamethasone (BPd), compared with standard-of-care pomalidomide, bortezomib